Sign Up
|
Sign In
Home
US Market
UK Market
News
My Portfolio
Forex
Forum
Cockpit
EuroTrader
Home
»
World
»
Europe
»
Belgium
»
Pharmaceuticals
»
UCB
UCB
UCB
(BRU-ENX)
Overview
Discussions
Advanced chart
News
Historical data
Recommendations
To view this page ensure that Adobe Flash Player version 10.0.0 or greater is installed.
Industry
:
Health Care
Sector
:
Pharmaceuticals & Biotechnology
€
39.02
Updated
17:00:00
ISIN: BE0003739530
Change %
0.9%
Change
0.3500
Volume
242,950
High
€
39.23
Low
€
38.08
Open
€ 38.82
Prev close
€ 38.67
# of shares
183.37M
Market cap
7,154.91M EUR
Intraday
Market closed
Tech analysis
Market is closed, opens at 08:00
Price development
Latest
1 week
1 month
3 mon
6 mon
1 year
39.02
1.9%
13.9%
26.9%
29.8%
20.5%
Insufficient flash player version
News about UCB
Subscribe To RSS Feed
Local
International
Announcements
23 March
UCB SA/NV: Convocation Annual Shareholders' Meeting
10 June
UCB verstevigt de strategische overeenkomst met WILEX
10 June
UCB renforce son alliance stratégique avec WILEX
18 May
Roch Doliveux van UCB wordt lid van de Raad van Bestuur van het Innovative Medicines Initiative
18 May
Roch Doliveux (UCB) rejoint le Conseil d'Administration de 'Innovative Medicines Initiative'
29 April
Patiëntgericht presteren door te innoveren
29 April
UCB: l'innovation au service des patients
29 April
Rapport intermédiaire - Cimzia®, Vimpat® et Neupro® continuent sur leur lancée
29 April
Interim-rapport - Cimzia®, Vimpat® en Neupro® groeien voort
23 April
UCB ontvangt van de Amerikaanse FDA een volledige antwoordbrief over Neupro® (Rotigotine)
23 April
UCB reçoit une « Complete Response Letter » de la FDA pour Neupro® (rotigotine)
No news for this instrument
More news
Company profile
No description
Version: LiveBranchBuild_20120516.1 - EUROWEB7 - 2012-05-17 23:57:19 - 2012-05-17 22:57:19 - 1000 - Website: OKAY